A comparison of the long-term durability of nevirapine, efavirenz and lopinavir in routine clinical practice in Europe: a EuroSIDA study

J Reekie, P Reiss, B Ledergerber, D Sedlacek, M Parczewski, J Gatell, C Katlama, G Fätkenheuer, J D Lundgren, A Mocroft, EuroSIDA study group

    24 Citationer (Scopus)

    Abstract

    The durability of combination antiretroviral therapy (cART) regimens can be measured as time to discontinuation because of toxicity or treatment failure, development of clinical disease or serious long-term adverse events. The aim of this analysis was to compare the durability of nevirapine, efavirenz and lopinavir regimens based on these measures.
    OriginalsprogEngelsk
    TidsskriftHIV Medicine
    Vol/bind12
    Udgave nummer5
    Sider (fra-til)259-68
    Antal sider10
    ISSN1464-2662
    DOI
    StatusUdgivet - 2011

    Fingeraftryk

    Dyk ned i forskningsemnerne om 'A comparison of the long-term durability of nevirapine, efavirenz and lopinavir in routine clinical practice in Europe: a EuroSIDA study'. Sammen danner de et unikt fingeraftryk.

    Citationsformater